Abstract
To attain a reliable outcome in electric field-based tumor treatments, dose planning is a must, and dose planning, in turn, requires establishing the dose–response relationship. But finding reliable dose and response parameters implies analyzing the electric field–tissue interaction, in particular, the inevitable appearance of complex electrolytic mass transfer processes and the inherent tissue damage. This review of electric field-based tumor treatments highlights the fundamental role played by the mass transfer of electrolytic species in the dose–response relationship. During the electrolysis process in electric field-based tumor treatments, electrochemical reactions take place at the electrodes, producing at the anode oxygen, chlorine, and protons as the main by-products, while hydrogen and hydroxide ions are released at the cathode. Proton and hydroxyls generation yields strong pH fronts. Since these fronts are the main product of electrolytic reactions, it is reasonable to assume that they are the main cause of tissue damage. The amount of electrolytic products emerging from chemical reactions is proportional to the amount of electric charges or Coulomb dose passing through the tissue; thus, Coulomb dose is proportional to tissue damage. Theory shows that in a constant electric field such as in electrolytic ablation, an optimal dose–response relationship is the minimum Coulomb dose necessary to achieve total tumor destruction while minimizing healthy tissue damage. In a pulsed electric field such as in gene electrotransfer, unwanted damage due to electrolysis is non-negligible; here, an optimal gene electrotransfer treatment is predicted as the critical Coulomb dose yielding maximum electroporated area with minimum damage. Theory shows that when tissue natural buffer is taken into account, damage is attenuated (though still remaining non-negligible), and the critical Coulomb dose for optimal gene electrotransfer increases.
Similar content being viewed by others
References
Chiarella P, Fazio VM, Signori E (2010) Application of electroporation in DNA vaccination protocols. Curr Gene Ther 10:281–286 (PMID: 20504275)
Colombo L, Gonzalez G, Marshall G, Molina F, Soba A, Suarez C, Turjanski P (2007) Ion transport in tumors under electrochemical treatment: in vivo, in vitro, and in silico modeling. Bioelectrochemistry 71:223–232
Davalos R, Mir L, Rubinsky B (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33:223–231
Li JH, **n YL, Zhang W, Liu JT, Quan KH (2006) Effect of electroacupuncture in treating patients with a lingual hemangioma. Chin J Integr Med 12(2):146–149
Luján E, Schinca H, Olaiz N, Urquiza S, Molina FV, Turjanski P, Marshall G (2015) Optimal dose-response relationship in electrolytic ablation of tumors with a one-probe-two-electrode device. Electrochim Acta 186:494–503
Maglietti F, Michinski S, Olaiz N, Castro M, Suárez C, Marshall G (2013) The role of Ph fronts in tissue electroporation-based treatments. PLoS One 8(11):e80167. doi:10.1371/journal.pone.0080167
Marino M, Olaiz N, Signori E, Maglietti F, Suarez C, Colombo L, Turjanski P, Michinski S, Luján E Marshall G (2014) Tissue damage in vaccination protocols based on electroporation: pH fronts and tissue natural buffering. In: 14th International Conference on Progress In Vaccination against Cancer PIVAC −14, Poster No. 22, Rome, Italy, in http://docplayer.net/6456060-Pivac-14-the-14-th-international-conference-on-progress-in-vaccination-against-cancer-24-26-september-2014-rome-italy.html#show_full_text
Marshall G (2014) Biomedical applications of electrochemistry, use of electric fields in cancer therapy. In: Savinell RF, Ota K, Kreysa G (eds) Encyclopedia of Applied Electrochemistry. Springer, New York. doi:10.1007/978-1-4419-6996-5_250 126-131
McMahon JM, Signori E, Wells KE, Fazio VM, Wells DJ (2001) Optimization of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase – increased expression with reduced muscle damage. Gene Ther 8:1264–1270
Nilsson E (2000) Modeling of the electrochemical treatment of tumors. PhD thesis, Department of Chemical Engineering and Technology, Applied Electrochemistry, Royal Institute of Technology
Nordenström B (1983) Biologically closed electrical circuits: clinical, experimental and theoretical evidence for an additional circulatory system. Nordic Medical Publications, Stockholm
Olaiz N, Suarez C, Risk M, Molina FV, Marshall G (2010a) Tracking protein electrodenaturation fronts in the electrochemical treatment of tumors. Electrochem Commun 12:94–97
Olaiz N, Maglietti F, Suárez C, Molina FV, Miklavcic D, Mir L, Marshall G (2010b) Electrochemical treatment of tumors using a one-probe two-electrode device. Electrochim Acta 55:6010–6014
Olaiz N, Signori E, Maglietti F, Soba A, Suárez C, Turjanski P, Michinski S, Marshall G (2014) Tissue damage modeling in plasmid gene electrotransfer: the role of pH. Bioelectrochemistry 100:105–111
Saulis G, Lape R, Prabeviciute R, Mickevicius D (2005) Changes of the solution pH due to exposure by high-voltage electric pulses. Bioelectrochemistry 67:101–108
Suárez C, Soba A, Maglietti F, Olaiz N, Marshall G (2014) The role of additional pulses in electropermeabilization protocols. PLoS One 9(12):e113413. doi:10.1371/journal.pone.0113413
Turjanski P, Olaiz N, Maglietti F, Michinski S, Suarez C, Molina FV, Marshall G (2011) The role of pH fronts in reversible electroporation. PLoS One 6(4):e17303. doi:10.1371/journal.pone.0017303
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2016 Springer International Publishing AG
About this entry
Cite this entry
Marshall, G. (2016). Mass Transfer of Electrolytic Species During Electric Field-Based Tumor Treatments. In: Miklavcic, D. (eds) Handbook of Electroporation. Springer, Cham. https://doi.org/10.1007/978-3-319-26779-1_68-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-26779-1_68-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Online ISBN: 978-3-319-26779-1
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences